Dr. Jorge Acosta is a Board Certified Surgeon and one of the first fellowship trained bariatric surgeons in the region. Dr. Acosta has performed over 4,500 laparoscopic bariatric procedures and is the most experienced robotic bariatric surgeon in the region.
Excellent results and low complication rates attest to his vast experience and medical expertise. Dr Jorge Acosta is one of the founders and currently serves as Medical Director for the Del Sol Multi-disciplinary Bariatric Center. He has obtained multiple distinctions from multiple surgical and medical societies. His role as Medical Director in the Del Sol comprehensive Weight Loss Surgery program has helped earned widespread recognition, including:
Dr. Acosta offers an extremely comprehensive program that includes dietary counseling by Certified Dieticians, psychological support, insurance liaisons, support groups and a complete medically based wellness program along with surgical intervention. Dr Jorge Acosta and his team are ready to provide the necessary support and resources to address the entire spectrum of care and needs of the bariatric patients.
Weight loss is just the beginning. If you’re ready for the next step, begin the first step and complete the On-line Informational Seminar
The Robotic Roux-en-Y Gastric Bypass (RYGBP) or "gastric bypass," is a minimally invasive FDA-approved long-standing surgical intervention for obesity. It can be performed as an initial procedure or revisional procedure after a sleeve gastrectomy if severe gastroesophageal reflux disease (GERD) develops. The procedure both decreases the size of the stomach, by creating a new stomach "pouch" approximately the size of an egg, and causes malabsorption by changing the way the small intestine (jejunum) is connected to the pouch. By altering this connection, food bypasses or goes around a portion of the small intestine.
With this procedure, there is a route for food through the new gastric pouch and a separate digestive enzyme route, connected to the old stomach. These two routes are reconnected at a different portion of the small intestine to allow your food and digestive enzymes to mix, thus, helping to digest food and absorb nutrients.
Gastric bypass typically produces approximately 70% of excess weight loss in 18 months. Gastric bypass is particularly good for patients with diabetes as it alters hormones that contribute to diabetes, and can cure GERD in 95% of patients. Individuals with a history of multiple kidney stones, extensive abdominal surgeries, or chronic diarrhea may not be good candidates for a gastric bypass. As with other bariatric procedures, adherence to lifelong vitamin, dietary, and protein supplementation is required for long-term success and health.
The robotic vertical sleeve gastrectomy is a minimally invasive FDA approved surgical intervention for obesity. During this procedure, approximately 80% of the stomach is removed, leaving a "tube" or "banana" shaped stomach. The portion of the stomach that is removed contains numerous hunger hormones called ghrelin, which assist with not feeling as hungry after surgery. No changes are made to how the intestines are connected during this procedure.
The gastric sleeve combined with adherence to dietary guidelines typically produces approximately 60% excess weight loss at one year after surgery. It is very good for patients with a history of kidney stones, or who have had numerous abdominal surgeries. It is not typically recommended for individuals with severe gastroesophageal reflux disease (GERD) as it can cause GERD or worsen existing GERD. As with all bariatric procedures, adherence to lifelong vitamin, dietary, and protein supplementation is required for long-term success and health.